Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Den Hartog

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2013
Clinical features differ substantially between Caucasian and Asian populations of Marfan syndromeRomy Franken, Alexander W den Hartog, Liz van de Riet, et al.
Expert Review of Cardiovascular Therapy|August 2, 2022
P2Y<sub>12</sub>-inhibitor monotherapy after coronary stenting: are all P2Y<sub>12</sub>-inhibitors equal?Niels Mr van der Sangen, I Tarik Küçük, Jurriën M Ten Berg, et al.
European Heart Journal|September 4, 2013
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trialMaarten Groenink, Alexander W den Hartog, Romy Franken, et al.
Radiology|June 27, 2013
Aortic disease in patients with Marfan syndrome: aortic volume assessment for surveillanceAlexander W den Hartog, Romy Franken, Piet de Witte, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 24, 2025
Comparison of Fractional Flow Reserve and Myocardial Perfusion Imaging in Saphenous Vein GraftsRoel Hoek, Ruben W de Winter, Rens T Peters, et al.
Journal of Clinical Medicine|September 28, 2023
First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP StudyAnna van Veelen, I Tarik Küçük, Federico H Fuentes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 1, 2024
Paclitaxel-coated balloons for vulnerable lipid-rich plaquesAnna van Veelen, I Tarik Küçük, Hector M Garcia-Garcia, et al.
Journal of Clinical Medicine|April 9, 2024
Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. <i>J. Clin. Med.</i> 2023, <i>12</i>, 5807Anna van Veelen, I Tarik Küçük, Federico H Fuentes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 1, 2025
The Impact of Hydrostatic Pressure on Fractional Flow Reserve in Saphenous Vein GraftsRoel Hoek, Sina Porouchani, Ruben W de Winter, et al.
Circulation. Cardiovascular Genetics|January 24, 2015
Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan SyndromeRomy Franken, Alexander W den Hartog, Teodora Radonic, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2013
Clinical features differ substantially between Caucasian and Asian populations of Marfan syndromeRomy Franken, Alexander W den Hartog, Liz van de Riet, et al.
Expert Review of Cardiovascular Therapy|August 2, 2022
P2Y<sub>12</sub>-inhibitor monotherapy after coronary stenting: are all P2Y<sub>12</sub>-inhibitors equal?Niels Mr van der Sangen, I Tarik Küçük, Jurriën M Ten Berg, et al.
European Heart Journal|September 4, 2013
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trialMaarten Groenink, Alexander W den Hartog, Romy Franken, et al.
Radiology|June 27, 2013
Aortic disease in patients with Marfan syndrome: aortic volume assessment for surveillanceAlexander W den Hartog, Romy Franken, Piet de Witte, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 24, 2025
Comparison of Fractional Flow Reserve and Myocardial Perfusion Imaging in Saphenous Vein GraftsRoel Hoek, Ruben W de Winter, Rens T Peters, et al.
Journal of Clinical Medicine|September 28, 2023
First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP StudyAnna van Veelen, I Tarik Küçük, Federico H Fuentes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 1, 2024
Paclitaxel-coated balloons for vulnerable lipid-rich plaquesAnna van Veelen, I Tarik Küçük, Hector M Garcia-Garcia, et al.
Journal of Clinical Medicine|April 9, 2024
Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. <i>J. Clin. Med.</i> 2023, <i>12</i>, 5807Anna van Veelen, I Tarik Küçük, Federico H Fuentes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 1, 2025
The Impact of Hydrostatic Pressure on Fractional Flow Reserve in Saphenous Vein GraftsRoel Hoek, Sina Porouchani, Ruben W de Winter, et al.
Circulation. Cardiovascular Genetics|January 24, 2015
Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan SyndromeRomy Franken, Alexander W den Hartog, Teodora Radonic, et al.
Pageof 4